6.40
price up icon5.79%   0.35
after-market After Hours: 6.37 -0.03 -0.47%
loading
Optimizerx Corp stock is traded at $6.40, with a volume of 324.69K. It is up +5.79% in the last 24 hours and up +0.00% over the past month. OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
See More
Previous Close:
$6.05
Open:
$6.08
24h Volume:
324.69K
Relative Volume:
0.72
Market Cap:
$120.08M
Revenue:
$109.43M
Net Income/Loss:
$5.13M
P/E Ratio:
24.56
EPS:
0.2606
Net Cash Flow:
$18.91M
1W Performance:
-1.54%
1M Performance:
+0.00%
6M Performance:
-68.61%
1Y Performance:
-23.17%
1-Day Range:
Value
$6.00
$6.43
1-Week Range:
Value
$5.77
$6.505
52-Week Range:
Value
$5.54
$22.25

Optimizerx Corp Stock (OPRX) Company Profile

Name
Name
Optimizerx Corp
Name
Phone
248-651-6558
Name
Address
260 CHARLES STREET, WALTHAM, MI
Name
Employee
105
Name
Twitter
@OpRxTweets
Name
Next Earnings Date
2025-03-12
Name
Latest SEC Filings
Name
OPRX's Discussions on Twitter

Compare OPRX vs VEEV, TEM, BTSG, HQY, WAY

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
OPRX icon
OPRX
Optimizerx Corp
6.40 113.51M 109.43M 5.13M 18.91M 0.2606
VEEV icon
VEEV
Veeva Systems Inc
167.30 25.98B 3.20B 908.91M 1.39B 5.4168
TEM icon
TEM
Tempus Ai Inc
56.41 8.89B 1.27B -245.03M -245.36M -1.4071
BTSG icon
BTSG
Brightspring Health Services Inc
46.01 8.89B 12.91B 104.80M 394.69M 0.8769
HQY icon
HQY
Healthequity Inc
83.67 6.87B 1.31B 215.20M 408.32M 2.4627
WAY icon
WAY
Waystar Holding Corp
24.68 4.30B 1.10B 112.09M 283.19M 0.6096

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-08-25 Downgrade RBC Capital Mkts Outperform → Sector Perform
Dec-20-24 Initiated Stephens Equal-Weight
Jul-25-24 Resumed B. Riley Securities Buy
Apr-04-24 Initiated JMP Securities Mkt Outperform
Jan-03-24 Initiated Barclays Equal Weight
Feb-02-23 Resumed B. Riley Securities Buy
Nov-01-22 Initiated Stifel Buy
Jul-15-22 Initiated SVB Leerink Outperform
Oct-18-21 Resumed B. Riley Securities Buy
Apr-13-21 Initiated RBC Capital Mkts Outperform
Jan-03-19 Initiated William Blair Outperform
View All

Optimizerx Corp Stock (OPRX) Latest News

pulisher
Apr 14, 2026

OPRX Cuts Revenue Outlook: Temporary Reset or Structural Concern? - qz.com

Apr 14, 2026
pulisher
Apr 14, 2026

OptimizeRx (OPRX) soars 5.9%: Is further upside left in the stock? - MSN

Apr 14, 2026
pulisher
Apr 11, 2026

If You Invested $1,000 in Optimizerx Corp (OPRX) - Stock Titan

Apr 11, 2026
pulisher
Apr 10, 2026

Whats the profit margin of OptimizeRx Corporation2026 Price Targets & Free Safe Capital Growth Stock Tips - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 09, 2026

OptimizeRx Corp. Receives Favorable Valuation Adjustment Amidst Profit Growth and High Institutional Confidence - Markets Mojo

Apr 09, 2026
pulisher
Apr 09, 2026

OptimizeRx Adds Microsoft Health Leader to Board - TipRanks

Apr 09, 2026
pulisher
Apr 08, 2026

OptimizeRx adds Microsoft Health exec to board of directors - Investing.com

Apr 08, 2026
pulisher
Apr 08, 2026

Microsoft health leader joins OptimizeRx (OPRX) board as independent director - Stock Titan

Apr 08, 2026
pulisher
Apr 08, 2026

OptimizeRx Appoints Microsoft Health & Life Sciences COO to Board - National Today

Apr 08, 2026
pulisher
Apr 08, 2026

OptimizeRx Appoints Mary Varghese Presti to Board of Directors - Bitget

Apr 08, 2026
pulisher
Apr 02, 2026

Are Investors Undervaluing OptimizeRx (OPRX) Right Now? - qz.com

Apr 02, 2026
pulisher
Apr 02, 2026

Best Value Stocks to Buy for March 16th - Eastern Progress

Apr 02, 2026
pulisher
Apr 02, 2026

What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now? - MSN

Apr 02, 2026
pulisher
Apr 01, 2026

OptimizeRx (OPRX) price target decreased by 40.41% to 14.79 - MSN

Apr 01, 2026
pulisher
Apr 01, 2026

New Top-Rated Stocks to Buy for April 1st - Bitget

Apr 01, 2026
pulisher
Apr 01, 2026

OPRX Should I Buy - Intellectia AI

Apr 01, 2026
pulisher
Mar 30, 2026

OptimizeRx (NASDAQ: OPRX) switches auditors from UHY LLP to Grant Thornton - Stock Titan

Mar 30, 2026
pulisher
Mar 29, 2026

OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 29, 2026
pulisher
Mar 27, 2026

Vanguard disaggregates holdings; OPRX parent reports 0 shares (OPRX) - Stock Titan

Mar 27, 2026
pulisher
Mar 27, 2026

OPRX Technical Analysis & ETF Price Forecast - Intellectia AI

Mar 27, 2026
pulisher
Mar 26, 2026

OptimizeRx (OPRX) Jumps 5.9%: Does the Stock Have More Room to Grow? - Bitget

Mar 26, 2026
pulisher
Mar 26, 2026

Earnings call transcript: OptimizeRx Q4 2025 earnings beat forecasts, stock dips - Investing.com Australia

Mar 26, 2026
pulisher
Mar 26, 2026

OPRX SEC FilingsOptimizerx Corp 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

OptimizeRx (OPRX) Soars 5.9%: Is Further Upside Left in the Stock? - finance.yahoo.com

Mar 26, 2026
pulisher
Mar 24, 2026

Best Value Stocks to Buy for March 24th - sharewise.com

Mar 24, 2026
pulisher
Mar 23, 2026

OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates - MSN

Mar 23, 2026
pulisher
Mar 20, 2026

Strength seen in OptimizeRx (OPRX): Can its 7.5% jump turn into more strength? - MSN

Mar 20, 2026
pulisher
Mar 20, 2026

OPRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 20, 2026
pulisher
Mar 20, 2026

Guidance Update: Can OptimizeRx Corporation sustain earnings growthEntry Point & Fast Entry Momentum Alerts - baoquankhu1.vn

Mar 20, 2026
pulisher
Mar 20, 2026

OPRX Technical Analysis & Stock Price Forecast - Intellectia AI

Mar 20, 2026
pulisher
Mar 19, 2026

How The OptimizeRx (OPRX) Narrative Is Shifting As Guidance Resets And Valuation Expectations Reprice - Yahoo Finance

Mar 19, 2026
pulisher
Mar 16, 2026

OptimizeRx Corp. (NASDAQ:OPRX) Short Interest Down 16.4% in February - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Is OptimizeRx (OPRX) Stock Undervalued Right Now? - Yahoo Finance

Mar 16, 2026
pulisher
Mar 15, 2026

Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? - MSN

Mar 15, 2026
pulisher
Mar 14, 2026

OptimizeRx Corp. (OPRX) Q4 earnings and revenues beat estimates - MSN

Mar 14, 2026
pulisher
Mar 12, 2026

OptimizeRx (OPRX) outlines AI-driven pharma marketing strategy and key risks - Stock Titan

Mar 12, 2026
pulisher
Mar 10, 2026

Should you sell your OptimizeRx stock? - Cantech Letter

Mar 10, 2026
pulisher
Mar 10, 2026

OptimizeRx Corporation Common Stock OPRX ) Stock Price Today & Analysis - Gotrade

Mar 10, 2026
pulisher
Mar 07, 2026

OptimizeRx Corporation (NASDAQ:OPRX) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 07, 2026

Optimizerx Corp Stock (OPRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Optimizerx Corp Stock (OPRX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Stelmakh Edward
Chief Finance & Strat Officer
Dec 19 '25
Sale
13.51
1,388
18,752
126,830
Silvestro Stephen L
Chief Executive Officer
Dec 19 '25
Option Exercise
0.00
6,546
0
195,462
Odence-Ford Marion
Chief Legal & Admin Officer
Dec 19 '25
Option Exercise
0.00
3,928
0
94,526
Besch Doug
Chief Product & Tech Officer
Dec 19 '25
Option Exercise
0.00
1,964
0
71,536
Odence-Ford Marion
Chief Legal & Admin Officer
Oct 03 '25
Option Exercise
0.00
6,649
0
92,550
Silvestro Stephen L
Chief Executive Officer
Oct 03 '25
Option Exercise
0.00
6,649
0
190,536
Silvestro Stephen L
Chief Executive Officer
Oct 03 '25
Sale
18.75
1,620
30,375
188,916
Stelmakh Edward
Chief Finance & Strat Officer
Oct 03 '25
Option Exercise
0.00
16,623
0
127,387
Besch Doug
Chief Product & Tech Officer
Oct 03 '25
Option Exercise
0.00
3,325
0
70,555
Spangler Patrick D
Director
Aug 28 '25
Sale
17.49
11,120
194,489
44,215
$23.44
price up icon 1.38%
TXG TXG
$25.35
price up icon 2.22%
$41.47
price up icon 6.94%
$15.22
price up icon 0.07%
$23.90
price up icon 7.42%
WAY WAY
$24.68
price up icon 10.03%
Cap:     |  Volume (24h):